CONQUERING CANCER. THAT'S IN OUR BLOOD. Trademark

Trademark Overview

On Thursday, May 15, 2014, a trademark application was filed for CONQUERING CANCER. THAT'S IN OUR BLOOD. with the United States Patent and Trademark Office. The USPTO has given the CONQUERING CANCER. THAT'S IN OUR BLOOD. trademark a serial number of 86978486. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 11, 2022. This trademark is owned by Cell Therapeutics, Inc.. The CONQUERING CANCER. THAT'S IN OUR BLOOD. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classificat...
conquering cancer. that's in our blood.

General Information

Serial Number86978486
Word MarkCONQUERING CANCER. THAT'S IN OUR BLOOD.
Filing DateThursday, May 15, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 11, 2022
Registration Number4948081
Registration DateTuesday, April 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2015

Trademark Statements

Pseudo MarkCONQUERING CANCER. THAT IS IN OUR BLOOD.
Goods and ServicesResearch, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 11, 2022
Primary Code042
First Use Anywhere DateSaturday, May 31, 2014
First Use In Commerce DateSaturday, May 31, 2014

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCTI BIOPHARMA CORP.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCTI BIOPHARMA CORP.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Friday, November 11, 2022CANCELLED SEC. 8 (6-YR)
Monday, April 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 15, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 26, 2016REGISTERED-PRINCIPAL REGISTER
Friday, March 25, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 24, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 9, 2016ASSIGNED TO LIE
Monday, March 7, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 7, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, March 4, 2016NOTICE OF PSEUDO MARK E-MAILED
Thursday, March 3, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 19, 2016USE AMENDMENT FILED
Thursday, March 3, 2016DIVISIONAL PROCESSING COMPLETE
Tuesday, January 19, 2016DIVISIONAL REQUEST RECEIVED
Tuesday, January 19, 2016TEAS REQUEST TO DIVIDE RECEIVED
Friday, February 26, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 19, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, August 4, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 2, 2015ASSIGNED TO LIE
Thursday, April 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, April 9, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 9, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, April 9, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, February 26, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 25, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 25, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 31, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION WRITTEN
Sunday, August 31, 2014ASSIGNED TO EXAMINER
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 29, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, May 28, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 19, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

blood cancer conquering research pharmaceutical medical development scientific life sciences fields pharmaceuticals